Acrivon Therapeutics, Inc. (ACRV) Operating income 2021–2025
Acrivon Therapeutics, Inc. (ACRV) annual operating income history from SEC filings — each fiscal year as reported.
-$84.1MFY2025 · since FY2021: -$16.2M → -$84.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.1M | +5.7% |
| FY2024 | -$89.2M | -32.9% |
| FY2023 | -$67.1M | -105.5% |
| FY2022 | -$32.7M | -101.8% |
| FY2021 | -$16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice